Pfiz­er plans to pull out of BIO, fol­low­ing moves by oth­er large drug­mak­ers to re­duce lob­by­ing foot­print

Pfiz­er is plan­ning to leave the Biotech­nol­o­gy In­no­va­tion Or­ga­ni­za­tion, a source fa­mil­iar with the mat­ter con­firmed to End­points News, as it will not re­new its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER